Tech Center 3600 • Art Units: 3681 3686
This examiner grants 37% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18426440 | SIMILAR CLINICAL TRIAL SEARCH SUPPORT SYSTEM AND SIMILAR CLINICAL TRIAL SEARCH SUPPORT METHOD | Final Rejection | Hitachi, Ltd. |
| 18667001 | REHABILITATION SUPPORT SYSTEM, REHABILITATION SUPPORT METHOD, AND STORAGE MEDIUM | Non-Final OA | TOYOTA JIDOSHA KABUSHIKI KAISHA |
| 18323640 | GENERATING CUMULANT-BASED RISK SCORES FOR DISEASES | Final Rejection | INTERNATIONAL BUSINESS MACHINES CORPORATION |
| 18332050 | METHODS AND APPARATUS FOR IDENTIFYING HIGH-RISK PATIENTS FOR PROTECTED PERCUTANEOUS CORONARY INTERVENTIONS | Non-Final OA | Abiomed, Inc |
| 18426433 | MEDICAL INFORMATION PROCESSING DEVICE, MEDICAL INFORMATION PROCESSING METHOD, AND STORAGE MEDIUM | Non-Final OA | CANON MEDICAL SYSTEMS CORPORATION |
| 19076698 | INVENTORY MANAGEMENT SYSTEM | Non-Final OA | VETSNAP CORP. |
| 18340310 | DEVICES, SYSTEMS, AND METHODS FOR GEOLOCATION-BASED SKIN SCIENCE-DRIVEN ENVIRONMENTAL EXPOSURE METRICS | Final Rejection | L'Oreal |
| 18993031 | METHOD, PROGRAM AND DEVICE FOR DIAGNOSING MYOCARDIAL INFARCTION USING ELECTROCARDIOGRAM | Non-Final OA | MEDICAL AI CO., LTD. |
| 19038743 | COMPUTER-READABLE RECORDING MEDIUM STORING INFORMATION OUTPUT PROGRAM, INFORMATION OUTPUT METHOD, AND INFORMATION PROCESSING DEVICE | Non-Final OA | Fujitsu Limited |
| 18908568 | SYSTEM AND METHOD FOR REMOTE PATIENT MONITORING | Final Rejection | University Health Network |
| 19025685 | HEALTHCARE MANAGEMENT SYSTEM | Non-Final OA | MyMedVita Inc. |
| 18990262 | Retrieval-Augmented Synthetic Test Claim Generation | Non-Final OA | Magnum Transaction Sub, LLC |
| 18027826 | METHODS FOR DETERMINING VARIANT FREQUENCY AND MONITORING DISEASE PROGRESSION | Non-Final OA | Foundation Medicine, Inc. |
| 18963451 | COLLABORATIVE, CONTINUOUS, AND COMPREHENSIVE RISK MANAGEMENT SYSTEM | Non-Final OA | Intellectual Frontiers LLC |
| 18030116 | ESTIMATING RESIDUAL RENAL FUNCTION | Final Rejection | GAMBRO LUNDIA AB |
| 18326004 | METHOD AND APPARATUS FOR PREDICTING PERSISTENT POSTCONCUSSIVE NEUROPSYCHIATRIC SYMPTOMS USING THALAMOCORTICAL COHERENCE | Final Rejection | TAIPEI MEDICAL UNIVERSITY |
| 18801050 | METHOD AND SYSTEM FOR DISTRIBUTING AND ACCESSING DIAGNOSTIC IMAGES ASSOCIATED WITH DIAGNOSTIC IMAGING REPORT | Final Rejection | RAMSOFT INC. |
| 18786328 | ARTIFICIAL-INTELLIGENCE TECHNIQUES FOR FORECASTING INTENSITY OF UNINTENDED MOTOR MOVEMENTS | Final Rejection | RUNE LABS, INC. |
| 18784092 | METHOD AND SYSTEM FOR PROGNOSTIC SURVIVAL STAGE PREDICTION BASED ON MACHINE LEARNING | Final Rejection | BEIHANG UNIVERSITY |
| 18192915 | IMAGE PROCESSING TO SUPPORT RADIATION THERAPY WORKFLOW STEPS | Non-Final OA | Siemens Healthineers International AG |
| 18710169 | Diagnostic Method and System | Final Rejection | Limbic Limited |
| 18645524 | DIGITAL THERAPEUTICS FOR IMPROVED NEURO-CONNECTIVITY | Final Rejection | REMEPY HEALTH LTD |
| 18241511 | SYSTEMS AND METHODS FOR MEDICAL PATIENT CLASSIFICATION | Non-Final OA | MCKINSEY & COMPANY, INC. |
| 18540583 | IDENTIFYING MATERNITY SEVERITY INDEX FOR WOMEN | Non-Final OA | INNOVACCER INC. |
| 18134189 | SYSTEM AND METHODS FOR CONTINUOUSLY ASSESSING PERFORMANCE OF PREDICTIVE ANALYTICS IN A CLINICAL DECISION SUPPORT SYSTEM | Non-Final OA | Etiometry Inc. |
| 18424389 | INSTRUMENT SELECTION OPTIMIZATION | Final Rejection | Pegasys Medical, Inc. |
| 18205744 | SYSTEMS AND METHODS FOR MONITORING IMPLANTABLE MEDICAL DEVICE USAGE AND TREATMENT PLAN ADHERENCE | Final Rejection | INSPIRE MEDICAL SYSTEMS, INC. |
| 18569619 | METHOD FOR NASH RISK ASSESSMENT IN PATIENTS HAVING A METABOLIC DISORDER | Final Rejection | GENFIT |
| 17927462 | APPARATUSES, SYSTEMS, AND METHODS FOR BIOMARKER COLLECTION, BI-DIRECTIONAL PATIENT COMMUNICATION AND LONGITUDINAL PATIENT FOLLOW-UP | Final Rejection | Compass Pathfinder Limited |
| 18099809 | Methods and Systems for Generating and Monitoring Holistic Treatment Processes | Non-Final OA | Vell LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy